Loading...
Why So Few Drugs for Alzheimer's Disease? Are Methods Failing Drugs?
Recent studies of Alzheimer's disease (AD) and other neuropsychiatric drug developments raise questions whether failures of some drugs occur due to flaws in methods. In three case studies of recent AD drug development failures with phenserine, metrifonate, and tarenflurbil we identified methodo...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3010269/ https://ncbi.nlm.nih.gov/pubmed/20704560 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|